In this meta-analysis, we compared fluoroquinolones monotherapy with ß-lactams plus macrolides combination therapy for the treatment of community acquired pneumonia (CAP)with respect to mortality, treatment success and adverse outcomes.
ABSTRACT
Objective: Several randomized trials have been done to compare fluoroquinolones alone with the combination therapy of β-lactams plus macrolides for treating community-acquired pneumonia (CAP) in adults. However, the efficacy and safety between the two arms are still unclear.
Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.